BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35163861)

  • 41. The prognostic value of the immunohistochemical aspects of tumor suppressor genes p53, bcl-2, PTEN and nuclear proliferative antigen Ki-67 in resected colorectal carcinoma.
    Ghiţă C; Vîlcea ID; Dumitrescu M; Vîlcea AM; Mirea CS; Aşchie M; Vasilescu F
    Rom J Morphol Embryol; 2012; 53(3):549-56. PubMed ID: 22990545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular prognostic factors in locally irresectable rectal cancer treated preoperatively by chemo-radiotherapy.
    Reerink O; Karrenbeld A; Plukker JT; Verschueren RC; Szabó BG; Sluiter WJ; Hospers GA; Mulder NH
    Anticancer Res; 2004; 24(2C):1217-21. PubMed ID: 15154650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
    Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
    Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
    Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
    Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator.
    Shih HC; Shiozawa T; Kato K; Imai T; Miyamoto T; Uchikawa J; Nikaido T; Konishi I
    Hum Pathol; 2003 May; 34(5):471-8. PubMed ID: 12792921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients.
    Abdulla M; Laszlo S; Triumf J; Hedström G; Berglund M; Enblad G; Amini RM
    Acta Oncol; 2016; 55(9-10):1126-1131. PubMed ID: 27549735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of p16, p53, and Ki-67 in colorectal adenocarcinoma: a study of 356 surgically resected cases.
    Huh JW; Lee JH; Kim HR
    Hepatogastroenterology; 2010; 57(101):734-40. PubMed ID: 21033219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
    Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
    Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis.
    Masuda M; Takano Y; Iki M; Asakura T; Hashiba T; Noguchi S; Hosaka M
    Pathol Int; 1998 Jan; 48(1):41-6. PubMed ID: 9589463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
    Baekelandt M; Kristensen GB; Nesland JM; Tropé CG; Holm R
    J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients.
    Fu CG; Tominaga O; Nagawa H; Nita ME; Masaki T; Ishimaru G; Higuchi Y; Tsuruo T; Muto T
    Dis Colon Rectum; 1998 Jan; 41(1):68-74. PubMed ID: 9510313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y; Wexner SD; Berho M
    Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.
    Engellau J; Persson A; Bendahl PO; Akerman M; Domanski HA; Bjerkehagen B; Lilleng P; Weide J; Rydholm A; Alvegård TA; Nilbert M
    Virchows Arch; 2004 Sep; 445(3):224-30. PubMed ID: 15309631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
    Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
    Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic significance of p53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy.
    Wiggenraad R; Tamminga R; Blok P; Rouse R; Hermans J
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):29-35. PubMed ID: 9588914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival predictors in patients with prostate adenocarcinoma with hormonal blockade.
    Angulo JC; Redondo C; Sánchez-Chapado M; Colás B; Ropero S; López JI
    Pathol Res Pract; 2016 Oct; 212(10):899-903. PubMed ID: 27502465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
    Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
    Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Survival of patients with laryngeal cancer and some prognostic factors].
    Gryczyński M; Kobos J; Murlewska A; Pietruszewska W
    Otolaryngol Pol; 2003; 57(3):329-40. PubMed ID: 14524174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
    Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
    Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.